Portfolio company
Aria CV, Inc
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This medical technology company develops an implantable balloon system to treat pulmonary arterial hypertension by restoring vessel compliance and reducing cardiac workload.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alleviant Medical
This medical device company develops a minimally invasive interatrial shunt therapy without a permanent implant to treat patients suffering from heart failure.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
CorWave
This company develops implantable heart pumps with membrane technology to provide pulsatile blood flow for patients suffering from advanced heart failure.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
CVRx
This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.
Alleviant
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
V-Wave
This company develops implantable interatrial shunts to regulate heart pressure and reduce hospitalisations for patients suffering from chronic heart failure.
DRUG-COATED BALLOON (DCB)
This company develops nanoparticle-based dual-drug-coated balloons for interventional cardiologists to treat coronary and peripheral artery disease without permanent implants.
